A prospective observational cohort study to identify the causes of anaemia and association with outcome in cardiac surgical patients

被引:66
作者
Hung, Matthew [1 ]
Ortmann, Erik [1 ]
Besser, Martin [2 ]
Martin-Cabrera, Pedro [2 ]
Richards, Toby [3 ]
Ghosh, Marcus [1 ]
Bottrill, Fiona [4 ]
Collier, Timothy [5 ]
Klein, Andrew A. [1 ]
机构
[1] Papworth Hosp, Dept Anaesthesia, Cambridge CB23 3RE, England
[2] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 2QQ, England
[3] UCL, Div Surg & Intervent Sci, London, England
[4] Papworth Hosp, Dept Res & Dev, Cambridge CB3 8RE, England
[5] London Sch Hyg & Trop Med, Dept Stat, London WC1, England
关键词
HEART-FAILURE; PREOPERATIVE ANEMIA; BLOOD-TRANSFUSION; IRON THERAPY; SURGERY; ERYTHROPOIETIN; MORTALITY; PREVALENCE; PREDICTOR; OLDER;
D O I
10.1136/heartjnl-2014-305856
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives Preoperative anaemia is associated with increased morbidity and mortality. We sought to determine the relative frequencies of the different causes of anaemia including absolute and functional iron deficiency, and the association of different haematological parameters, including plasma hepcidin, a key protein responsible for iron regulation, with outcomes after cardiac surgery. Methods Prospective observational study between January 2012 and 2013; 200 anaemic cardiac surgical patients were recruited and 165 were studied. Detailed blood and bone marrow analysis was performed. Primary outcome was days alive and out of hospital. Results Mean (SD) haemoglobin (Hb) was 102 (8) g/L for women and 112 (11) g/L for men. Regarding outcomes, 137 (83%) patients were transfused at least one unit of red blood cells; 30-day mortality was 1.8% (three patients). Functional iron deficiency was diagnosed in 78 patients (47%). Plasma hepcidin concentration was the only haematological variable associated with outcome, with mean days alive and out of hospital 2.7 (95% CI 0.4 to 5.1) days less if hepcidin >= 20 ng/mL compared with < 20 ng/mL (p=0.024). Multivariable analysis showed that the association between hepcidin and outcome was independent of risk (European System for Cardiac Operative Risk Evaluation), transfusion and Hb. Conclusions Functional iron deficiency was the most common cause of anaemia but was not associated with outcome. The only haematological parameter that was associated with outcome was hepcidin concentration, which is a novel finding and introduces further complexity into our understanding of the role of iron and its regulation by hepcidin. We propose that future research should target patients with elevated hepcidin.
引用
收藏
页码:107 / 112
页数:6
相关论文
共 28 条
[1]   Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency. [J].
Anker, Stefan D. ;
Comin Colet, Josep ;
Filippatos, Gerasimos ;
Willenheimer, Ronnie ;
Dickstein, Kenneth ;
Drexler, Helmut ;
Luescher, Thomas F. ;
Bart, Boris ;
Banasiak, Waldemar ;
Niegowska, Joanna ;
Kirwan, Bridget-Anne ;
Mori, Claudio ;
Rothe, Barbara von Eisenhart ;
Pocock, Stuart J. ;
Poole-Wilson, Philip A. ;
Ponikowski, Piotr .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (25) :2436-2448
[2]   Days alive and out of hospital and the patient journey in patients with heart failure: Insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program [J].
Ariti, Cono A. ;
Cleland, John G. F. ;
Pocock, Stuart J. ;
Pfeffer, Marc A. ;
Swedberg, Karl ;
Granger, Christopher B. ;
McMurray, John J. V. ;
Michelson, Eric L. ;
Ostergren, Jan ;
Yusuf, Salim .
AMERICAN HEART JOURNAL, 2011, 162 (05) :900-906
[3]   Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis [J].
Avni, Tomer ;
Leibovici, Leonard ;
Gafter-Gvili, Anat .
EUROPEAN JOURNAL OF HEART FAILURE, 2012, 14 (04) :423-429
[4]   IRON-HF study: A randomized trial to assess the effects of iron in heart failure patients with anemia [J].
Beck-da-Silva, Luis ;
Piardi, Diogo ;
Soder, Stephan ;
Rohde, Luis Eduardo ;
Pereira-Barretto, Antonio Carlos ;
de Albuquerque, Denilson ;
Bocchi, Edimar ;
Vilas-Boas, Fabio ;
Moura, Lidia Zytynzki ;
Montera, Marcelo W. ;
Rassi, Salvador ;
Clausell, Nadine .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (04) :3439-3442
[5]   Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia [J].
Bregman, David B. ;
Morris, David ;
Koch, Todd A. ;
He, Andy ;
Goodnough, Lawrence T. .
AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (02) :97-101
[6]   Effects of Preoperative Intravenous Erythropoietin Plus Iron on Outcome in Anemic Patients After Cardiac Valve Replacement [J].
Cladellas, Merce ;
Farre, Nuria ;
Comin-Colet, Josep ;
Gomez, Miquel ;
Merono, Oona ;
Alba Bosch, M. ;
Vila, Joan ;
Molera, Rosa ;
Segovia, Anna ;
Bruguera, Jordi .
AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (07) :1021-1026
[7]   Anemia in heart failure - Time to rethink its etiology and treatment? [J].
Dec, G. William .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (12) :2490-2492
[8]  
Gartlehner G, 2013, COCHRANE DB SYST REV, V3
[9]   Concepts of blood transfusion in adults [J].
Goodnough, Lawrence T. ;
Levy, Jerrold H. ;
Murphy, Michael F. .
LANCET, 2013, 381 (9880) :1845-1854
[10]   Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia [J].
Guralnik, JM ;
Eisenstaedt, RS ;
Ferrucci, L ;
Klein, HG ;
Woodman, RC .
BLOOD, 2004, 104 (08) :2263-2268